MARKET WIRE NEWS

Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript

Source: SeekingAlpha

2025-03-17 10:22:42 ET

Protalix BioTherapeutics, Inc. (PLX)

Q4 2024 Earnings Conference Call

March 17, 2025 8:30 AM ET

Company Participants

Mike Moyer - Investor Relations, LifeSci Advisors

Dror Bashan - President and Chief Executive Officer

Eyal Rubin - Senior Vice President and Chief Financial Officer

Conference Call Participants

Ram Selvaraju - H.C. Wainwright

John Vandermosten - Zach's SCR

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics Fiscal Year 2024 Financial and Business Results Conference Call. As a reminder, this conference call is being recorded.

I will now turn the conference over to your host, Mr. Mike Moyer of LifeSci Advisors, Investor Relations for Protalix. You may begin your conference....

Read the full article on Seeking Alpha

For further details see:

Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript
Protalix BioTherapeutics Inc.

NASDAQ: PLX

PLX Trading

0.89% G/L:

$2.825 Last:

353,729 Volume:

$2.82 Open:

mwn-link-x Ad 300

PLX Latest News

PLX Stock Data

$215,126,659
70,448,955
0.23%
25
N/A
Biotechnology & Life Sciences
Healthcare
US
Hackensack

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App